Cargando…

PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumors

Aims: To evaluate the biological significance of dense vascular networks associated with low-grade NENs, we assessed the impact of PDGFRα tissue expression in 77 GEP/NEN patients, associating PDGFRα expression with the morphological characterization in low-grade tumors. Methods and results: Paraffin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavalcanti, Elisabetta, Ignazzi, Antonia, De Michele, Francesco, Caruso, Maria Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422502/ https://www.ncbi.nlm.nih.gov/pubmed/30346879 http://dx.doi.org/10.1080/15384047.2018.1529114

Ejemplares similares

Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
por: Das, Satya, et al.
Publicado: (2021)

Mucin phenotype of differentiated early gastric cancer: an immunohistochemistry study supporting therapeutic decision making
por: Cavalcanti, Elisabetta, et al.
Publicado: (2019)

Small bowel capsule endoscopy revealing neuromuscular and vascular hamartoma of the jejunum: A case report
por: Caruso, Maria L., et al.
Publicado: (2018)

Increased nerve twigs in small intestinal mucosa with programmed cell death-ligand 1 and somatostatin receptor type 2A expression in recurrent Crohn disease: A case report
por: Caruso, Maria Lucia, et al.
Publicado: (2018)

Primary Well-Differentiated Neuroendocrine Tumor of the Kidney
por: Prasad, Vishnu, et al.
Publicado: (2023)

microRNA-140 Regulates PDGFRα and Is Involved in Adipocyte Differentiation
por: Yan, Yi, et al.
Publicado: (2022)

PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα
por: Fantauzzo, Katherine A., et al.
Publicado: (2016)

Transcriptome analysis of PDGFRα(+) cells identifies T-type Ca(2+) channel CACNA1G as a new pathological marker for PDGFRα(+) cell hyperplasia
por: Ha, Se Eun, et al.
Publicado: (2017)

Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
por: Romagnoli, Simone, et al.
Publicado: (2021)

Lycorine inhibits angiogenesis by docking to PDGFRα
por: Lv, Fei, et al.
Publicado: (2022)

Two well-differentiated pancreatic neuroendocrine tumor mouse models
por: Wong, Chung, et al.
Publicado: (2019)

Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein
por: Li, Xiaoguang, et al.
Publicado: (2017)

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading
por: Cavalcanti, Elisabetta, et al.
Publicado: (2017)

Cryopreservation and validation of differentiated PDGFRα-positive cells for long term usage in experimentation
por: Srivastava, Ankita, et al.
Publicado: (2023)

PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
por: Bai, Feng, et al.
Publicado: (2021)

Telocytes express PDGFRα in the human gastrointestinal tract
por: Vannucchi, Maria-Giuliana, et al.
Publicado: (2013)

Transanal Endoscopic Microsurgery for the Treatment of Well-Differentiated Rectal Neuroendocrine Tumors
por: Kim, Hyoung Ran, et al.
Publicado: (2012)

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
por: Kotteas, Elias A, et al.
Publicado: (2016)

Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
por: Jiang, Hua, et al.
Publicado: (2022)

Gallbladder primary well-differentiated neuroendocrine tumor: A misdiagnosed case
por: Dammak, Nouha, et al.
Publicado: (2023)

Well‑differentiated neuroendocrine tumor of the right kidney: A case report
por: Yang, Denghao, et al.
Publicado: (2023)

Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
por: Henderson, Amy, et al.
Publicado: (2023)

Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics
por: Bahlawane, Christelle, et al.
Publicado: (2015)

Transcriptome profiling of subepithelial PDGFRα cells in colonic mucosa reveals several cell-selective markers
por: Ha, Se Eun, et al.
Publicado: (2022)

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study
por: Berruti, Alfredo, et al.
Publicado: (2014)

hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
por: Chauhan, Aman, et al.
Publicado: (2022)

Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma
por: Yamada, Shutaro, et al.
Publicado: (2017)

Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
por: Li, Su-Chen, et al.
Publicado: (2013)

Well-differentiated neuroendocrine tumor of the stomach: A rare case at an uncommon site
por: Gumuscu, Burak, et al.
Publicado: (2016)

Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors
por: Cheng, Yue-Juan, et al.
Publicado: (2018)

Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
por: Santos, Ana P., et al.
Publicado: (2018)

Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor
por: Williamson, Laura M., et al.
Publicado: (2019)

Grade 3 well-differentiated neuroendocrine tumor of the rectum: a case report
por: Ito, Misato, et al.
Publicado: (2020)

Recurrent Gastrointestinal Pseudo-obstruction Because of Well-Differentiated Duodenal Neuroendocrine Tumor
por: Sharma, Ruchi, et al.
Publicado: (2022)

Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors
por: Wong, Jocelyn P., et al.
Publicado: (2016)

AKT1-CREB stimulation of PDGFRα expression is pivotal for PTEN deficient tumor development
por: Wan, Xiaofeng, et al.
Publicado: (2021)

Cardiac telocytes are double positive for CD34/PDGFR-α
por: Zhou, Qiulian, et al.
Publicado: (2015)

Generation of PDGFRα(+) Cardioblasts from Pluripotent Stem Cells
por: Hong, Seon Pyo, et al.
Publicado: (2017)

PDGFRα: Expression and Function during Mitral Valve Morphogenesis
por: Moore, Kelsey, et al.
Publicado: (2021)

Consequences of PDGFRα(+) fibroblast reduction in adult murine hearts
por: Kuwabara, Jill T, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8eo4u85ub642ct1p5qq5c3hd8b